News and Trends 21 Mar 2023 Karuna Therapeutics sees positive schizophrenia trial results …said David Walling, chief clinical officer at Cenexel – CNS and investigator on the EMERGENT-3 trial. “The results from the EMERGENT-3 trial add to the growing body of data which… March 21, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2022 Trial and new drug for Tourette Syndrome after $250M after funding round completed …was created by Paragon Biosciences in 2018 to develop novel treatments for central nervous system (CNS) disorders. Jeff Aronin, Emalex founder and Paragon Biosciences CEO, said: “Emalex was founded specifically… November 3, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2024 The biggest private biotech investments in August 2024 …by central nervous system (CNS), immunology, rare disease, and renal disease companies. Table of contents Biggest biotech investments by value in August 2024 August 2024 saw Borealis Biosciences bring in… September 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by MC Services 10 Mar 2023 Meet some of the biotechs attending Bio-Europe Spring 2023 …Bio-Europe Spring 2023. Newron Headquartered in Italy, Newron is a biopharma that is focused on the drug development of innovative treatments for central nervous system (CNS) disorders. The company has… March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Mar 2025 12 AI drug discovery companies you should know about …protein degradation technologies, particularly in oncology and central nervous system (CNS) diseases, with the goal of unlocking new therapeutic pathways for conditions with limited treatment options. This is one of… March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email